Articles citing this paper
Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2
Martin F. Pera and Daniella Herszfeld
10(8) pp.551 - 556
30 articles found in Crossref database.
Local Therapies for Glioma Present Status and Future Developments (2003)
Oct-4 mRNA and protein expression during human preimplantation development
Cauffman G.,
Van de Velde H.,
Liebaers I., Van Steirteghem A.
MHR: Basic science of reproductive medicine. 2004 11(3). p.173
BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line
Wang Lin,
Park Paul,
Zhang Huina,
La Marca Frank,
Claeson Amy,
Valdivia Juan, Lin Chia-Ying
Cancer Biology & Therapy. 2011 11(5). p.457
Assessment of pluripotency and multilineage differentiation potential of NTERA‐2 cells as a model for studying human embryonic stem cells
Pal Rajarshi, Ravindran Geeta
Cell Proliferation. 2006 39(6). p.585
Role of gain of 12p in germ cell tumour development
LOOIJENGA LEENDERT H. J.,
ZAFARANA GAETANO,
GRYGALEWICZ BEATA,
SUMMERSGILL BRENDA,
DEBIEC‐RYCHTER MARIA,
VELTMAN JORIS,
SCHOENMAKERS ERIC F. P. M.,
RODRIGUEZ SANDRINE,
JAFER OSMAN,
CLARK JEREMY,
VAN KESSEL AD GEURTS,
SHIPLEY JANET,
VAN GURP RUUD J. H. L. M.,
GILLIS AD J. M., OOSTERHUIS J. WOLTER
APMIS. 2003 111(1). p.161
Enhancement of Embryonic Stem Cell Differentiation Promoted by Avian Chorioallantoic Membranes
Talavera-Adame Dodanim,
Dafoe Donald C.,
Ng Tina T.,
Wachsmann-Hogiu Sebastian,
Castillo-Henkel Carlos, Farkas Daniel L.
Tissue Engineering Part A. 2009 15(10). p.3193
Human embryonic stem cells: prospects for development
Pera Martin F., Trounson Alan O.
Development. 2004 131(22). p.5515
Y chromosome in Turner syndrome: review of the literature
Oliveira Rose Mary Rocco de,
Verreschi Ieda Therezinha do Nascimento,
Lipay Monica Vannucci Nunes,
Eça Lilian Piñero,
Guedes Alexis Dourado, Bianco Bianca
Sao Paulo Medical Journal. 2009 127(6). p.373
Human Embryonic Stem Cells (2003)
Constitutive Gene Expression Predisposes Morphogen-Mediated Cell Fate Responses of NT2/D1 and 27X-1 Human Embryonal Carcinoma Cells
Chadalavada Rajendrakumar S. V.,
Korkola James E.,
Houldsworth Jane,
Olshen Adam B.,
Bosl George J.,
Studer Lorenz, Chaganti R. S. K.
Stem Cells. 2007 25(3). p.771
Encyclopedia of Molecular Cell Biology and Molecular Medicine (2006)
Identification and characterization of cancer stem cells in ovarian yolk sac tumors
Suzuki Shiro,
Terauchi Mikio,
Umezu Tomokazu,
Kajiyama Hiroaki,
Shibata Kiyosumi,
Nawa Akihiro, Kikkawa Fumitaka
Cancer Science. 2010 101(10). p.2179
TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells’ Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer
Gordeeva Olga
Cells. 2019 8(12). p.1500
Octamer 4 Small Interfering RNA Results in Cancer Stem Cell–Like Cell Apoptosis
Hu Tingsong,
Liu Shanrong,
Breiter Deborah R.,
Wang Fang,
Tang Ying, Sun Shuhan
Cancer Research. 2008 68(16). p.6533
Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors
Yu Chi-Ho,
Hwang Du-Na,
Yhee Ji-Young,
Kim Jong-Hyuk,
Im Keum-Soon,
Nho Whan-Gook,
Lyoo Young-Soo, Sur Jung-Hyang
Journal of Veterinary Science. 2009 10(1). p.1
Handbook of Stem Cells (2004)
Stem cell origin of cancer and differentiation therapy
Sell Stewart
Critical Reviews in Oncology/Hematology. 2004 51(1). p.1
Cloning and characterization of the rabbitPOU5F1gene
Shi Jian J.,
Cai Dong H.,
Chen Xue J., Sheng Hui Z.
DNA Sequence. 2008 19(1). p.56
From teratocarcinomas to embryonic stem cells
Andrews Peter W.
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 2002 357(1420). p.405
Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin
Pera Martin F.,
Andrade Jessica,
Houssami Souheir,
Reubinoff Benjamin,
Trounson Alan,
Stanley Edouard G.,
Oostwaard Dorien Ward-van, Mummery Christine
Journal of Cell Science. 2004 117(7). p.1269
Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS
Makino Hatsune,
Toyoda Masashi,
Matsumoto Kenji,
Saito Hirohisa,
Nishino Koichiro,
Fukawatase Yoshihiro,
Machida Masakazu,
Akutsu Hidenori,
Uyama Taro,
Miyagawa Yoshitaka,
Okita Hajime,
Kiyokawa Nobutaka,
Fujino Takashi,
Ishikawa Yuichi,
Nakamura Takuro, Umezawa Akihiro
Experimental Cell Research. 2009 315(16). p.2727
Human Embryonal Carcinoma Stem Cells: Models of Embryonic Development in Humans
Przyborski S.A.,
Christie V.B.,
Hayman M.W.,
Stewart R., Horrocks G.M.
Stem Cells and Development. 2004 13(4). p.400
Handbook of Stem Cells (2013)
Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells
Kelly Gregory M., Gatie Mohamed I.
Stem Cells International. 2017 2017 p.1
Human pluripotent embryonal carcinoma NTERA2 cl.D1 cells maintain their typical morphology in an angiomyogenic medium
Simões Pedro D, Ramos Teresa
Journal of Negative Results in BioMedicine. 2007 6(1).
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
Reubinoff Benjamin E.,
Pera Martin F.,
Fong Chui-Yee,
Trounson Alan, Bongso Ariff
Nature Biotechnology. 2000 18(4). p.399
The disparate role of BMP in stem cell biology
Varga Alison C, Wrana Jeffrey L
Oncogene. 2005 24(37). p.5713
Advances and Technical Standards in Neurosurgery (2003)
Contemporary Oral Oncology (2017)
CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells
Herszfeld Daniella,
Wolvetang Ernst,
Langton-Bunker Emma,
Chung Tung-Liang,
Filipczyk Adam A,
Houssami Souheir,
Jamshidi Pegah,
Koh Karen,
Laslett Andrew L,
Michalska Anna,
Nguyen Linh,
Reubinoff Benjamin E,
Tellis Irene,
Auerbach Jonathan M,
Ording Carol J,
Looijenga Leendert H J, Pera Martin F
Nature Biotechnology. 2006 24(3). p.351
